Evaluation of sample integrity measurement with VITROS® 5,1 FS chemistry system

LaboratoriumsMedizin

Volumn 33, Issue 1, 2009, Pages 33-38

  Knabbe, Cornelius ^a   Ratge, Dieter ^a   Christen, Klaus ^a   Sonntag, Oswald ^b,c  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b Scientific Affairs ^*  (Germany)

^c Ortho Clinical Diagnostics GmbH   (Germany)

Author keywords

Hemolysis; Icterus; Interference; Turbidity; VITROS 5,1 FS

Indexed keywords

BILIRUBIN; HEMOGLOBIN; TRIACYLGLYCEROL;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; JAUNDICE; OPTICS; PH MEASUREMENT; PHOTOMETER; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDITY;

EID: 59049097310     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2009.008     Document Type: Article

References (36)

1. Kohn L, Corrigan J, Donaldson M, editors. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
2. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691-8.
3. Kalra J. Medical errors: an introduction to concepts. Clin Biochem 2004;37:1043-51.
4. Kalra J. Medical errors: impact on clinical laboratories and other critical areas. Clin Biochem 2004;37:1052-62.
5. Kalra J. Medical errors: overcoming the challenges. Clin Biochem 2004;37:1063-71.
6. Astion ML, Shojania KG, Hamill TR, Kim S, Ng VL. Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol 2003;120:18-26.
7. Glick MR, Ryder KW, Glick SJ, Woods JR. Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. Clin Chem 1989;35:837-9.
8. Ryder KW, Glick MR, Glick SJ. Incidence and amount of turbidity, hemolysis, and icterus in serum from outpatients. Lab Med 1991;22:415-8.
9. Sonntag O, Glick MR. Serum-Index und Interferogramm - Ein neuer Weg zur Prüfung und Darstellung von Interferenzen durch Serumchromogene. Lab Med 1989;13:77-82.
10. Glick MR, Ryder KW, Vroon DH, Masters BE, Sonntag O. Practical uses of serum indices to reduce errors from lipemia, icterus, and hemolysis. [Abstract 262]. Clin Chem 1990;36:1008.
11. Hawkins RC. Discrepancy between visual and spectrophotometric assessment of sample haemolysis. Ann Clin Biochem 2002;39:521-2.
12. Onifade K, Morgan B, Harris P, Billings K, Mohammad A, Petersen J, Okorodudu AO. Visual vs. automated estimation of hemolysis, icterus and turbidity [Abstract A-160]. Clin Chem 2005;51:A51.
13. Kwon HJ, Seo EJ, Min KO. The influence of hemolysis, turbidity and icterus on the measurements of CK-MB, troponin I and myoglobin. Clin Chem Lab Med 2003;41:360-4.
14. Hawkins RC. Poor knowledge and faulty thinking regarding hemolysis and potassium elevation. Clin Chem Lab Med 2005;43:216-20.
15. Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem 1986;24:127-39.
16. Blank DW, Kroll MH, Ruddel ME, Elin RJ. Hemoglobin interference from in vivo hemolysis. Clin Chem 1985;31:1566-9.
17. Kroll MH. Evaluating interference caused by lipemia. Clin Chem 2004;50:1968-9.
18. Bornhorst JA, Roberts RF, Roberts WL. Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. Clin Chem 2004;50:2197-201.
19. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306-7.
20. Dimeski G, Clague AE, Hickman PE. Correction and reporting of potassium results in haemolysed samples. Ann Clin Biochem 2005;42:119-23.
21. Randall AG, Garcia-Webb P, Beilby JP. Interference by haemolysis, icterus and lipaemia in assays on the Beckman Synchron CX5 and methods for correction. Ann Clin Biochem 1990;27:345-52.
22. Jay DW, Provasek D. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. Clin Chem 1993;39:1804-10.
23. Twomey PJ, Don-Wauchope AC, McCullough D. Unreliability of triglyceride measurement to predict turbidity induced interference. J Clin Pathol 2003;56:861-2.
24. Guder WG, da Fonseca-Wollheim F, Heil W, Schmitt YM, Töpfer G, Wisser H, Zawta B. The haemolytic, icteric and lipemic sample - recommendations regarding their recognition and prevention of clinically relevant interferences. J Lab Med 2000;24:357-64.
25. Ryder KW, Glick MR. Erroneous laboratory results from hemolyzed, icteric, and lipemic specimens. Clin Chem 1993;39:175-6.
26. Glick MR, Ryder KW. Analytical systems ranked by freedom from interferences. Clin Chem 1987;33:1453-8.
27. Hübl W, Wejbora R, Shafti-Keramat I, Haider A, Hajdusich P, Bayer PM. Enzymatic determination of sodium, potassium, and chloride in abnormal (hemolyzed, icteric, lipemic, paraproteinemic, or uremic) serum samples compared with indirect determination with ion-selective electrodes. Clin Chem 1994;40:1528-31.
28. Pearson JR, Wells R, Wells A. Serum index identifies lipemic samples causing interference with bilirubin assay on Hitachi 717. Clin Chem 1991;37:2014-5.
29. Bakkeren DL, van den Bergh FAJTM. Storende invloeden van hemolyse, lipemie en bilirubine op 22 routine-chemie-bepalingen: het gebruik van serumindices onderzocht op de Hitachi 717. Tijdschr NVKC 1990;15:152-7.
30. Flood J, Liedtke R, Mattenheimer H, Rothouse L, Trundle D, Vronn D, et al. A multicenter evaluation of the Boehringer Mannheim Hitachi 717 system. Clin Chem 1990;23:477-88.
31. Vermeer HJ, Thomassen E, de Jonge N. Automated processing of serum indices used for interference detection by the laboratory information system. Clin Chem 2005;51:244-7.
32. Warren K, Sawyer B, Cheehan T, Merrill G, Mehalek G, Li C, Least Jr C. Interference evaluation of the VITROS 5,1 FS chemistry system MicroSensor (sample integrity) module [Abstract A55]. Clin Chem 2002;48:6.
33. Douglas L, Love J, Mehalek G, Sawyer B, Steelman M. Analyte-specific specimen quality measurement with the VITROS 5,1 FS chemistry system [Abstract M-131]. Clin Chem Lab Med 2003;41(Suppl 116):5116.
34. Harboe M. A method for the determination of hemoglobin in plasma by near ultraviolet spectrophotometry. Scand J Clin Lab Invest 1959;11:66-70.
35. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
36. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;307-10.